Zidovudine Triphosphate Levels in Maternal and Infant Cord Blood Cells

This study focuses on understanding how a drug called zidovudine triphosphate (AZT-TP) behaves inside the cells of pregnant women and their babies. The goal is to see how much of this drug is present in the blood cells of both mother and baby. This research is important because it can help doctors understand how well the drug is transferred from mother to baby during pregnancy, which could improve care for expectant mothers and their newborns. In this observational study, researchers will measure the levels of AZT-TP in the blood cells of both mothers and their babies. They will also compare these levels to the amounts of other natural substances in the cells. By doing so, they aim to understand how effectively the drug is transferred through the placenta, the organ that connects the mother and baby during pregnancy. This study does not involve any direct treatment or intervention, but rather observes and measures the drug's natural behavior in the body.